Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases

被引:60
作者
Jiang, Ziying
Yin, Xi
Wang, Miao
Chen, Tong
Wang, Yuanyuan
Gao, Zhongbao [1 ]
Wang, Zhenfu [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Dept Neurol, Beijing 100853, Peoples R China
关键词
ketogenic diet; ketone bodies; neuroinflammation; neurodegenerative diseases; experimental and clinical evidence; PROLIFERATOR-ACTIVATED RECEPTOR; CHAPERONE-MEDIATED AUTOPHAGY; MILD COGNITIVE IMPAIRMENT; GLYCATION END-PRODUCTS; BETA-HYDROXYBUTYRATE; KETONE-BODIES; MOUSE MODEL; MONOCARBOXYLATE TRANSPORTER; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE;
D O I
10.14336/AD.2021.1217
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The ketogenic diet (KD) is a low- carbohydrate, high-fat and adequate-protein diet. As a diet mimicking fasting, it triggers the production of ketone bodies (KBs) and brings the body into a state of ketosis. Recent and accumulating studies on humans and animal models have shown that KD is beneficial to neurodegenerative diseases through modulating central and peripheral metabolism, mitochondrial function, inflammation, oxidative stress, autophagy, and the gut microbiome. Complicated interplay of metabolism, gut microbiome, and other mechanisms can regulate neuroinflammation in neurodegenerative diseases by activating multiple molecular and cellular pathways. In this review, we detail the physiological basis of the KD, its functions in regulating neuroinflammation, and its protective role in normal brain aging and neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). We aimed to elucidate the underlying neuroinflammatory mechanisms of KD therapies in neurodegenerative diseases and provide novel insights into their application for neurodegenerative disease prevention and treatment.
引用
收藏
页码:1146 / 1165
页数:20
相关论文
共 197 条
[1]   β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms [J].
Achanta, Lavanya B. ;
Rae, Caroline D. .
NEUROCHEMICAL RESEARCH, 2017, 42 (01) :35-49
[2]   Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease [J].
Akhtar, Ansab ;
Sah, Sangeeta Pilkhwal .
NEUROCHEMISTRY INTERNATIONAL, 2020, 135
[3]  
Aman Y., 2021, NATURE AGING, V1, P634
[4]   State of the science on mild cognitive impairment (MCI) [J].
Anderson, Nicole D. .
CNS SPECTRUMS, 2019, 24 (01) :78-87
[5]   Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells [J].
Ang, Qi Yan ;
Alexander, Margaret ;
Newman, John C. ;
Tian, Yuan ;
Cai, Jingwei ;
Upadhyay, Vaibhav ;
Turnbaugh, Jessie A. ;
Verdin, Eric ;
Hall, Kevin D. ;
Leibel, Rudolph L. ;
Ravussin, Eric ;
Rosenbaum, Michael ;
Patterson, Andrew D. ;
Turnbaugh, Peter J. .
CELL, 2020, 181 (06) :1263-+
[6]   Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model [J].
Ari, Csilla ;
Poff, Angela M. ;
Held, Heather E. ;
Landon, Carol S. ;
Goldhagen, Craig R. ;
Mavromates, Nicholas ;
D'Agostino, Dominic P. .
PLOS ONE, 2014, 9 (07)
[7]   Triheptanoin Supplementation to Ketogenic Diet Curbs Cognitive Impairment in APP/PS1 Mice Used as a Model of Familial Alzheimer's Disease [J].
Aso, Ester ;
Semakova, Jana ;
Joda, Laura ;
Semak, Vladislav ;
Halbaut, Lyda ;
Calpena, Ana ;
Escolano, Carmen ;
Perales, Jose C. ;
Ferrer, Isidro .
CURRENT ALZHEIMER RESEARCH, 2013, 10 (03) :290-297
[8]   Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue [J].
Asrih, Mohamed ;
Altirriba, Jordi ;
Rohner-Jeanrenaud, Francoise ;
Jornayvaz, Francois R. .
PLOS ONE, 2015, 10 (05)
[9]   Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders [J].
Augustin, Katrin ;
Khabbush, Aziza ;
Williams, Sophie ;
Eaton, Simon ;
Orford, Michael ;
Cross, J. Helen ;
Heales, Simon J. R. ;
Walker, Matthew C. ;
Williams, Robin S. B. .
LANCET NEUROLOGY, 2018, 17 (01) :84-93
[10]   KETONE-BODY PRODUCTION AND DISPOSAL - EFFECTS OF FASTING, DIABETES, AND EXERCISE [J].
BALASSE, EO ;
FERY, F .
DIABETES-METABOLISM REVIEWS, 1989, 5 (03) :247-270